To some extent, EpCAM-positive CTCs are a substantial subgroup of all CTCs, thus EpCAM-positive CTCs still could be a reliable biomarker if the cancer prognosis and therapeutic efficacy is relevant to EpCAM-positive CTCs. This evidence concerns the gene EPCAM and cancer.